FierceBiotech ٢١ مايو ٢٠٢٦ ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
FierceBiotech ٢١ مايو ٢٠٢٦ Lilly’s triple-G drug helps patients lose roughly a quarter of weight, showcasing competitive profile
FierceBiotech ٢١ مايو ٢٠٢٦ Infex, following in Insmed’s footsteps, advances lung disease candidate after clearing phase 2a
FierceBiotech ٢٠ مايو ٢٠٢٦ US taps small San Diego biotech for experimental Ebola treatment as epidemic worsens
FierceBiotech ٢٠ مايو ٢٠٢٦ GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
FierceBiotech ٢٠ مايو ٢٠٢٦ With $30M launch, Oorja Bio breathes new life into South Korean fibrosis candidate
FierceBiotech ٢٠ مايو ٢٠٢٦ Lilly pens $202M deal for preclinical DNA delivery biotech Engage as M&A streak continues
FierceBiotech ٢٠ مايو ٢٠٢٦ BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
FierceBiotech ٢٠ مايو ٢٠٢٦ Immunovant pays out $39M to call time on FcRn inhibitor after eye disease phase 3 fails
FierceBiotech ٢٠ مايو ٢٠٢٦ Parabilis, fresh from inking Regeneron pact, plans IPO to fund tumor drug’s phase 3 push
FierceBiotech ٢٠ مايو ٢٠٢٦ Pfizer furthers pneumococcal efforts, remains ‘comfortable’ taking on emerging threats: vaccine chief